Gene · 11091
Papers2,554
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,554
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The non-specific lethal complex regulates genes and pathways genetically linked to Parkinson's disease. | Brain | 2023 | 37522749 | PubTator, text mining | PubMed |
| First steps toward a BIG change: A pilot study to implement the Brain Injury Guidelines across a 24-hospital system. | Am J Surg | 2023 | 37517901 | PubTator, text mining | PubMed |
| The HDAC6-RNF168 axis regulates H2A/H2A.X ubiquitination to enable double-strand break repair. | Nucleic Acids Res | 2023 | 37503842 | PubTator, text mining | PubMed |
| NAT10-mediated N4-acetylcytidine mRNA modification regulates self-renewal in human embryonic stem cells. | Nucleic Acids Res | 2023 | 37497776 | PubTator, text mining | PubMed |
| 3D environment controls H3K4 methylation and the mechanical response of the nucleus in acute lymphoblastic leukemia cells. | Eur J Cell Biol | 2023 | 37494871 | PubTator, text mining | PubMed |
| Development of an orally bioavailable selective inhibitor of the menin-MLL. | Genes Dis | 2023 | 37492738 | PubTator, text mining | PubMed |
| Multilevel regulation of N6-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities. | Genes Dis | 2023 | 37492716 | PubTator, text mining | PubMed |
| Construction of a novel immune response prediction signature to predict the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma patients. | Heliyon | 2023 | 37484396 | PubTator, text mining | PubMed |
| The role of PKN1 in glioma pathogenesis and the antiglioma effect of raloxifene targeting PKN1. | J Cell Mol Med | 2023 | 37480215 | PubTator, text mining | PubMed |
| Direct mapping of ligandable tyrosines and lysines in cells with chiral sulfonyl fluoride probes. | Nat Chem | 2023 | 37460812 | PubTator, text mining | PubMed |
| Long noncoding RNA LINC01594 inhibits the CELF6-mediated splicing of oncogenic CD44 variants to promote colorectal cancer metastasis. | Cell Death Dis | 2023 | 37452042 | PubTator, text mining | PubMed |
| Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance. | Cancers (Basel) | 2023 | 37444568 | PubTator, text mining | PubMed |
| The Talented LncRNAs: Meshing into Transcriptional Regulatory Networks in Cancer. | Cancers (Basel) | 2023 | 37444543 | PubTator, text mining | PubMed |
| WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade Gliomas. | Cancers (Basel) | 2023 | 37444539 | PubTator, text mining | PubMed |
| Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial-Mesenchymal Transition. | Cancers (Basel) | 2023 | 37444447 | PubTator, text mining | PubMed |
| Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers. | Cells | 2023 | 37443779 | PubTator, text mining | PubMed |
| A novel signature of aging-related genes associated with lymphatic metastasis for survival prediction in patients with bladder cancer. | Front Oncol | 2023 | 37441420 | PubTator, text mining | PubMed |
| Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance. | Adv Sci (Weinh) | 2023 | 37436087 | PubTator, text mining | PubMed |
| The novel epithelial-mesenchymal transition-related proteins and their therapeutic targets in cholangiocarcinoma: a narrative review. | J Gastrointest Oncol | 2023 | 37435208 | PubTator, text mining | PubMed |
| The role of DNA methylation in human pancreatic neuroendocrine tumours. | Endocr Oncol | 2023 | 37434653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11091/papers?page=15